-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Gilead Sciences, Inc. quarterly Earnings Per Share, Diluted history and growth rate for Q2 2010.
- Gilead Sciences, Inc. Earnings Per Share, Diluted for the quarter ending June 30, 2010 was 0.79 pure.
Earnings Per Share, Diluted, Quarterly (pure)